HomeEMMA • OTCMKTS
add
Emmaus Life Sciences Inc
Previous close
$0.10
Day range
$0.10 - $0.10
Year range
$0.051 - $0.34
Market cap
5.36M USD
Avg Volume
4.67K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 5.02M | 1.60% |
Operating expense | 4.78M | -5.51% |
Net income | 67.00K | 117.14% |
Net profit margin | 1.34 | 116.92% |
Earnings per share | — | — |
EBITDA | 32.00K | 104.94% |
Effective tax rate | 36.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.50M | 27.65% |
Total assets | 47.45M | 12.45% |
Total liabilities | 83.78M | 5.00% |
Total equity | -36.33M | — |
Shares outstanding | 53.64M | — |
Price to book | -0.15 | — |
Return on assets | 0.12% | — |
Return on capital | -2.60% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 67.00K | 117.14% |
Cash from operations | 58.00K | 106.08% |
Cash from investing | -399.00K | 55.67% |
Cash from financing | 494.00K | -76.63% |
Net change in cash | 144.00K | -26.90% |
Free cash flow | -1.89M | 56.33% |
About
Founded
1987
Headquarters
Website
Employees
13